Literature DB >> 20526574

Salmonella-allies in the fight against cancer.

Sara Leschner1, Siegfried Weiss.   

Abstract

Cancer has become the second ranking cause of death in the industrialized world. Conventional anti-cancer therapies such as surgery, radiotherapy, and chemotherapy are effective in the treatment of solid tumors only to some extent. Furthermore, they are often associated with severe side effects. Use of bacteria as alternative cancer therapeutics has sporadically been followed over more than a century. The potential to target and colonize solid tumors could be shown for many different bacteria in the meantime. Such bacteria are either obligate anaerobic bacteria like Clostridium or Bifidobacterium or facultative anaerobic like Escherichia coli or Salmonella. Here we describe bacterial strains that were successfully applied mostly in animals bearing model tumors, although first clinical trials have been reported as well. Our review mainly concentrates on Salmonella enterica serovar Typhimurium (S. Typhimurium) since these bacteria were studied most intensively thus far. Importantly, S. Typhimurium were shown not only to colonize large established tumors but also exhibit the property to invade and affect metastases. We report on a potential mechanism by which such bacteria can invade solid tumors. Furthermore, we describe several successful attempts in which the bacteria have been used as carriers for recombinant therapeutic molecules that render bacteria more powerful in eradication of the established tumor. Such attempts should be considered starting points on the way to an effective and safe tumor therapy with the help of bacteria.

Entities:  

Mesh:

Year:  2010        PMID: 20526574     DOI: 10.1007/s00109-010-0636-z

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  88 in total

1.  Attenuated Salmonella typhimurium containing interleukin-2 decreases MC-38 hepatic metastases: a novel anti-tumor agent.

Authors:  D A Saltzman; C P Heise; D E Hasz; M Zebede; S M Kelly; R Curtiss; A S Leonard; P M Anderson
Journal:  Cancer Biother Radiopharm       Date:  1996-04       Impact factor: 3.099

2.  Genetically engineered Bifidobacterium longum for tumor-targeting enzyme-prodrug therapy of autochthonous mammary tumors in rats.

Authors:  Takayuki Sasaki; Minoru Fujimori; Yoshinori Hamaji; Yoshihisa Hama; Ken-Ichi Ito; Jun Amano; Shun'ichiro Taniguchi
Journal:  Cancer Sci       Date:  2006-07       Impact factor: 6.716

3.  Bacterial delivery of a novel cytolysin to hypoxic areas of solid tumors.

Authors:  R M Ryan; J Green; P J Williams; S Tazzyman; S Hunt; J H Harmey; S C Kehoe; C E Lewis
Journal:  Gene Ther       Date:  2009-01-29       Impact factor: 5.250

4.  Exogenous cytosine deaminase gene expression in Bifidobacterium breve I-53-8w for tumor-targeting enzyme/prodrug therapy.

Authors:  Ayumi Hidaka; Yoshinori Hamaji; Takayuki Sasaki; Shun'ichiro Taniguchi; Minoru Fujimori
Journal:  Biosci Biotechnol Biochem       Date:  2007-12       Impact factor: 2.043

5.  Oral delivery of tumor-targeting Salmonella for cancer therapy in murine tumor models.

Authors:  Li-Jun Jia; Dong-Ping Wei; Qi-Ming Sun; Yan Huang; Qiang Wu; Zi-Chun Hua
Journal:  Cancer Sci       Date:  2007-05-13       Impact factor: 6.716

6.  Containment of tumor-colonizing bacteria by host neutrophils.

Authors:  Kathrin Westphal; Sara Leschner; Jadwiga Jablonska; Holger Loessner; Siegfried Weiss
Journal:  Cancer Res       Date:  2008-04-15       Impact factor: 12.701

7.  Attenuated Salmonella engineered to produce human cytokine LIGHT inhibit tumor growth.

Authors:  Markus Loeffler; Gaelle Le'Negrate; Maryla Krajewska; John C Reed
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-24       Impact factor: 11.205

8.  Attenuated bacteria as effectors in cancer immunotherapy.

Authors:  Basel K Al-Ramadi; Maria J Fernandez-Cabezudo; Hussain El-Hasasna; Suhail Al-Salam; Samir Attoub; Damo Xu; Salem Chouaib
Journal:  Ann N Y Acad Sci       Date:  2008-09       Impact factor: 5.691

Review 9.  Clostridia in cancer therapy.

Authors:  Nigel P Minton
Journal:  Nat Rev Microbiol       Date:  2003-12       Impact factor: 60.633

10.  Efficacy of a genetically-modified Salmonella typhimurium in an orthotopic human pancreatic cancer in nude mice.

Authors:  Chisa Nagakura; Katsuhiro Hayashi; Ming Zhao; Kensuke Yamauchi; Norio Yamamoto; Hiroyuki Tsuchiya; Katsuro Tomita; Michael Bouvet; Robert M Hoffman
Journal:  Anticancer Res       Date:  2009-06       Impact factor: 2.480

View more
  42 in total

1.  A bioluminescent transposon reporter-trap identifies tumor-specific microenvironment-induced promoters in Salmonella for conditional bacterial-based tumor therapy.

Authors:  Kelly Flentie; Brandon Kocher; Seth T Gammon; Deborah V Novack; Jeffrey S McKinney; David Piwnica-Worms
Journal:  Cancer Discov       Date:  2012-05-03       Impact factor: 39.397

2.  Tumor-specifically hypoxia-induced therapy of SPRY1/2 displayed differential therapeutic efficacy for melanoma.

Authors:  Zhipeng Liu; Xiufeng Liu; Wenmin Cao; Zi-Chun Hua
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

3.  Accumulation of single-stranded DNA in Escherichia coli carrying the colicin plasmid pColE3-CA38.

Authors:  Magali Morales; Hedieh Attai; Kimberly Troy; David Bermudes
Journal:  Plasmid       Date:  2014-11-05       Impact factor: 3.466

4.  Contribution of Veillonella parvula to Pseudomonas aeruginosa-mediated pathogenicity in a murine tumor model system.

Authors:  Christian Pustelny; Uliana Komor; Vinay Pawar; Anne Lorenz; Agata Bielecka; Annette Moter; Benjamin Gocht; Denitsa Eckweiler; Mathias Müsken; Claudia Grothe; Heinrich Lünsdorf; Siegfried Weiss; Susanne Häussler
Journal:  Infect Immun       Date:  2014-11-10       Impact factor: 3.441

5.  Trg-deficient Salmonella colonize quiescent tumor regions by exclusively penetrating or proliferating.

Authors:  Miaomin Zhang; Neil S Forbes
Journal:  J Control Release       Date:  2014-12-15       Impact factor: 9.776

Review 6.  Salmonella-Mediated Cancer Therapy: Roles and Potential.

Authors:  Vu Hong Nguyen; Jung-Joon Min
Journal:  Nucl Med Mol Imaging       Date:  2016-06-01

7.  Systemic administration of attenuated Salmonella typhimurium in combination with interleukin-21 for cancer therapy.

Authors:  Yuxuan Wang; Jianxiang Chen; Bo Tang; Xiangyu Zhang; Zi-Chun Hua
Journal:  Mol Clin Oncol       Date:  2013-03-11

8.  An integrative computational approach to effectively guide experimental identification of regulatory elements in promoters.

Authors:  Igor V Deyneko; Siegfried Weiss; Sara Leschner
Journal:  BMC Bioinformatics       Date:  2012-08-16       Impact factor: 3.169

9.  Identification of tumor-specific Salmonella Typhimurium promoters and their regulatory logic.

Authors:  Sara Leschner; Igor V Deyneko; Stefan Lienenklaus; Kathrin Wolf; Helmut Bloecker; Dirk Bumann; Holger Loessner; Siegfried Weiss
Journal:  Nucleic Acids Res       Date:  2011-12-02       Impact factor: 16.971

10.  Intravaginal live attenuated Salmonella increase local antitumor vaccine-specific CD8+ T cells.

Authors:  Loane Decrausaz; Christelle Pythoud; Sonia Domingos-Pereira; Laurent Derré; Patrice Jichlinski; Denise Nardelli-Haefliger
Journal:  Oncoimmunology       Date:  2013-01-01       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.